Yearly PSA screening highly effective for reducing prostate cancer deaths
/A recent study of over 400,000 men under the age of 80 years found that prostate specific antigen (PSA) screening every 12 to 18 months decreased prostate cancer mortality and all-cause mortality risk by a significant 64% and 24% respectively, among men aged 55 to 74 years.
Read More